GSK
GSK plcCompany with tickers: GSK, GLAXF
CIK
1131399
CUSIP
37733W204
Shares Outstanding
2,004,414,458
Website
https://www.gsk.com/
Investor Relations
https://www.gsk.com/investor-relations
13F Activity (30d)
217 filings
199 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2021-01-26 | — | |
| 6-K | 2021-02-01 | — | |
| 6-K | 2021-02-03 | — | |
| 6-K | 2021-02-04 | — | |
| 6-K | 2021-02-10 | — | |
| 6-K | 2021-02-12 | — | |
| 6-K | 2021-02-16 | — | |
| 6-K | 2021-02-17 | — | |
| 6-K | 2021-02-18 | — | |
| 6-K | 2021-02-19 | — | |
| 6-K | 2021-02-22 | — | |
| 6-K | 2021-02-23 | — | |
| 6-K | 2021-02-24 | — | |
| 6-K | 2021-02-25 | — | |
| 6-K | 2021-03-01 | — | |
| 6-K | 2021-03-02 | — | |
| 6-K | 2021-03-09 | — | |
| 6-K | 2021-03-10 | — | |
| 6-K | 2021-03-11 | — | |
| 20-F | 2021-03-12 | 2020-12-31 | |
| 6-K | 2021-03-15 | — | |
| 6-K | 2021-03-16 | — | |
| 6-K | 2021-03-17 | — | |
| 6-K | 2021-03-23 | — | |
| 6-K | 2021-03-24 | — | |
| 6-K | 2021-03-30 | — | |
| 6-K | 2021-04-01 | — | |
| 6-K | 2021-04-06 | — | |
| 6-K | 2021-04-09 | — | |
| 6-K | 2021-04-12 | — | |
| 6-K | 2021-04-14 | — | |
| 6-K | 2021-04-15 | — | |
| 6-K | 2021-04-16 | — | |
| 6-K | 2021-04-23 | — | |
| 6-K | 2021-04-26 | — | |
| 6-K | 2021-04-28 | — | |
| 6-K | 2021-05-04 | — | |
| 6-K | 2021-05-05 | — | |
| 6-K | 2021-05-06 | — | |
| 6-K | 2021-05-11 | — | |
| 6-K | 2021-05-13 | — | |
| 6-K | 2021-05-17 | — | |
| 6-K | 2021-05-18 | — | |
| 6-K | 2021-05-21 | — | |
| 6-K | 2021-05-24 | — | |
| 6-K | 2021-05-27 | — | |
| 6-K | 2021-06-01 | — | |
| 6-K | 2021-06-04 | — | |
| 6-K | 2021-06-09 | — | |
| 6-K | 2021-06-11 | — |
Showing 101–150 of 836 filings